StonvexLoading…
StonvexStonvexStonvexCore line items from NVAX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.12B | $682.16M | $983.71M | $1.98B |
Operating Income | $452.80M | $-248.93M | $-566.51M | $-644.74M |
Net Income | $440.30M | $-187.50M | $-545.06M | $-657.94M |
EPS (Diluted) | $2.58 | $-1.23 | $-5.41 | $-8.42 |
Total Assets | $1.18B | $1.56B | $1.80B | $2.26B |
Total Liabilities | $1.30B | $2.18B | $2.51B | $2.89B |
Cash & Equivalents | $240.63M | $530.23M | $568.50M | $1.34B |
Free Cash Flow OCF − CapEx | $-250.19M | $-100.32M | $-767.74M | $-504.99M |
Shares Outstanding | 162.58M | 160.42M | 139.51M | 86.04M |